IRVINE, CA and LISBON, PORTUGAL--(Marketwire - September 15, 2008) - Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today that new data on the Edwards SAPIEN transcatheter heart valve with the Ascendra transapical delivery system were presented at the 22nd annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS) in Lisbon, Portugal.
